Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-06-17Clinical Trial Update: PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease
This clinical trial update discusses a PET/MR imaging study in Parkinson's disease patients, including both short- and long-standing cases. …
-
CLINICAL_TRIALS research · 2016-06-17Clinical Trial Update: Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease [NA]
A clinical trial update describing the optimization of functional MRI protocols to study basal ganglia activation in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide [Phase 1]
Phase 1 trial evaluating the pharmacokinetic and pharmacodynamic interaction between the experimental agent BIA 3-202 and levodopa/benserazi…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Parkinsonian Brain Repair Using Human Stem Cells [Phase 1]
Phase 1 clinical trial evaluating brain repair using human stem cells for idiopathic Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease. [NA]
A completed clinical trial comparing two rehabilitation programs in patients with mild to moderate Parkinson's disease to assess relative ef…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-06-13Clinical Trial Update: Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography. [NA]
This clinical trial investigates the mesocorticolimbic pathway involved in impulse control disorders in Parkinson's disease using tensor dif…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Follow Up Study for Treatment of Parkinson's Disease With Deep Brain Stimulation
This document reports a completed follow-up clinical trial evaluating deep brain stimulation for Parkinson's disease, with results posted in…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Effects of Transcranial Direct Current Stimulation on Fine Motor Skills in Parkinson's Disease: a Pilot Study [NA]
A completed pilot study evaluated whether transcranial direct current stimulation improves fine motor skills, including handwriting, in Park…
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients [NA]
A clinical trial investigating brain-wave monitoring in response to visual and/or auditory stimulation in Parkinson's disease patients; curr…
-
FDA approval · 2016-06-03FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
FDA approval · 2016-06-03FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Carbidopa and Levodopa from Zydus Pharmaceuticals USA Inc., broadening the product's approva…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of melatonin prolonged-release and clonazepam for REM sleep behavior disorder in Parkinson …
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's Disease [NA]
Completed clinical trial evaluating the effects of virtual reality on functional capacity and quality of life in people with Parkinson disea…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: A Randomized Controlled Pilot Trial Comparing Irish Set Dancing to Usual Care for People With Parkinson's Disease [NA]
This completed randomized pilot trial compared Irish Set Dancing to usual care for people with Parkinson's disease to assess feasibility and…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study [NA]
A completed EEG study examining how subthalamic nucleus deep brain stimulation influences emotional conflict decision-making in Parkinson's …
-
FDA approval · 2016-05-31FDA Approved: AMANTADINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved amantadine hydrochloride as a generic product under an original application from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients [Phase 1]
Phase 1 study comparing plasma levels of levodopa, carbidopa, and entacapone after TRIGEL infusion versus Duodopa infusion in Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa [Phase 1]
Phase 1 study evaluating the pharmacokinetic–pharmacodynamic interaction between BIA 3-202 and levodopa/carbidopa in Parkinson's disease. Th…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures [NA]
This ClinicalTrials.gov update outlines a study evaluating sensor-based balance training and its impact on patient outcome measures. The stu…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease [Phase 4]
A Phase 4 clinical trial investigates the effect of melatonin on sleep disturbances in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202 [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics, pharmacodynamics, and food interaction of BIA 3-202 in Parkinson's disease; …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202 [Phase 1]
A completed Phase 1 study evaluating the tolerability, steady-state pharmacokinetics, and erythrocyte COMT inhibition of BIA 3-202 in Parkin…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites [Phase 1]
Phase 1 study evaluating the absorption, distribution, metabolism, and excretion of [14C]-labelled BIA 3-202 and its metabolites in Parkinso…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease [Phase 2]
Phase 2 trial evaluating a high-intensity exercise and fall-prevention boot camp for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Resistance Versus Balance Training in Parkinson's Disease [NA]
The University of Kiel-conducted clinical trial comparing resistance training versus balance training in Parkinson's disease has been comple…